Showing results (2001-2010 of 2,029) with videos related to

Sort By:
Pageof 203
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2017
Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian CancerDouglass W Tucker, Christopher R Getchell, Eric T McCarthy, et al.
Transfusion|July 11, 2025
ABO-mismatched platelet and plasma transfusion practices and the potential for transfusion-related alpha-gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative StudyNancy M Dunbar, Richard M Kaufman, Karina S Bary, et al.
Transfusion Medicine Reviews|May 28, 2013
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
Bio-Design and Manufacturing|December 9, 2024
Biofabrication and biomanufacturing in Ireland and the UKJack F Murphy, Martha Lavelle, Lisa Asciak, et al.
Immunity|September 26, 2025
S. aureus exposure during cutaneous antigen sensitization causes basophil- and interleukin-4-dependent exaggerated food anaphylaxisMrinmoy Das, Mohammed Alasharee, Brian Woods, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 6, 2021
Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trialAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Nature Medicine|January 10, 2017
Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activityArnab Ghosh, Melody Smith, Scott E James, et al.
Transfusion|August 26, 2017
An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) studyMichelle P Zeller, Rebecca Barty, Astrid Aandahl, et al.
Cell|September 18, 2012
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanomaChristine Guo Lian, Yufei Xu, Craig Ceol, et al.
Molecular Cancer|December 18, 2025
Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progressionErik Rasbach, Laure Migayron, Anne Brandenburg, et al.
Pageof 203